事業内容
あなたはここにいる:ホーム > 事業内容 > 薬物製剤 > 製剤化予備検討
With a very small quantity of active pharmaceutical ingredients (API) or druggable candidate molecules, Medicilon’s pre-formulation service can provide valuable information and expertise to guide the compounds to next steps. Our pre-formulation team has extensive experience on handling a wide range of compounds and we can suggest the path forward for early success.
Preclinical Candidate Characterization
Enabling Formulation Development for Screening
関連研究室